OR
About
OriginCell is a biomedical equipment enterprise that develops tumor immuno-therapy solutions. It develops tumor therapies and cellular drugs through the use of the 10-phage display library, humanized antibody technology platform, and antibody discovery platform that enable their medical facilities to apply in cancer treatments. OriginCell was founded in 2014 and is headquartered in Shanghai, China.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 29 investors are based in Pudong, Shandong, China.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Pudong, China
Contact Information
Find more investors like OriginCell
Search Investors